Is a fasting plasma glucose of 128 mg/dL and an HbA1c of 5.8 % diagnostic of diabetes or prediabetes?

Diagnostic Classification: Prediabetes

With a fasting plasma glucose of 128 mg/dL and HbA1c of 5.8%, this patient meets diagnostic criteria for prediabetes, not diabetes. The fasting glucose exceeds the diabetes threshold (≥126 mg/dL), but the HbA1c falls within the prediabetes range (5.7-6.4%), creating diagnostic discordance that requires careful interpretation. 1

Diagnostic Criteria Analysis

Why This is Prediabetes, Not Diabetes

According to the 2025 American Diabetes Association Standards of Care, diabetes diagnosis requires either:

• FPG ≥126 mg/dL, OR
• HbA1c ≥6.5%, OR
• 2-hour plasma glucose ≥200 mg/dL during OGTT, OR
• Random glucose ≥200 mg/dL with symptoms 1

However, in the absence of unequivocal hyperglycemia, diagnosis requires two abnormal results from different tests obtained either simultaneously or at two different time points. 1

The Critical Issue: Test Discordance

Your patient has:

• FPG of 128 mg/dL = meets diabetes threshold (≥126 mg/dL) 1
• HbA1c of 5.8% = prediabetes range (5.7-6.4%), NOT diabetes range (≥6.5%) 1

This discordance means you cannot diagnose diabetes based on a single elevated FPG when the HbA1c contradicts it. The HbA1c reflects chronic glucose exposure over 2-3 months and has better preanalytic stability and lower within-person variability than fasting glucose. 1

Recommended Next Steps

Confirm the Diagnosis

Repeat testing is mandatory before labeling this patient as diabetic. You should:

1. Repeat the FPG on a different day to confirm whether it remains ≥126 mg/dL 1
2. Consider an oral glucose tolerance test (OGTT) with 2-hour plasma glucose measurement, as this identifies more individuals with diabetes and prediabetes than FPG or HbA1c alone 1, 2
3. If repeat FPG is ≥126 mg/dL AND HbA1c remains <6.5%, the patient still has prediabetes by HbA1c criteria but diabetes by FPG criteria—this warrants OGTT for definitive classification 2, 3

Why OGTT Matters

Research demonstrates that using FPG alone misses a substantial proportion of diabetes cases, and HbA1c has low sensitivity (24.9%) when assessed against combined FPG and 2-hour glucose criteria. 2 The 2-hour plasma glucose during OGTT diagnoses more people with abnormal glucose metabolism than either FPG or HbA1c alone. 1

Clinical Implications

Current Classification: Prediabetes

Based on the HbA1c of 5.8%, this patient definitively has prediabetes (defined as HbA1c 5.7-6.4%). 1 The single elevated FPG of 128 mg/dL also meets prediabetes criteria (FPG 100-125 mg/dL), though it marginally exceeds this range. 1

Risk Stratification

This patient appears to have elevated risk prediabetes (meeting at least one criterion clearly, with borderline elevation on another). Individuals with HbA1c 5.7-6.0% have a 5-year diabetes incidence of 9-25%, while those with HbA1c 6.0-6.5% have 25-50% risk. 1 At 5.8%, this patient falls in the moderate-to-high risk category. 1

Approximately 10% of people with prediabetes progress to diabetes annually in the US. 4 Prediabetes also increases cardiovascular event rates (8.75 excess events per 10,000 person-years) and mortality (7.36 excess deaths per 10,000 person-years). 4

Common Pitfalls to Avoid

Don't Diagnose Diabetes Prematurely

The most critical error would be diagnosing diabetes based on a single FPG of 128 mg/dL when the HbA1c contradicts this. 1 FPG has high within-person variability and is affected by acute factors like stress, recent illness, food intake, and diurnal variation. 1

Don't Ignore the Discordance

FPG, 2-hour PG, and HbA1c reflect different aspects of glucose metabolism and have incomplete concordance. 1 Age, race, and other factors affect the relationship between these tests. 2 Older patients and certain racial groups show greater discordance between HbA1c and glucose-based criteria. 2

Consider Factors Affecting HbA1c

Before accepting the HbA1c as accurate, evaluate for conditions that alter erythrocyte turnover: anemia, iron deficiency, recent blood loss or transfusion, hemolysis, hemoglobin variants, renal failure, or pregnancy. 1 These can falsely lower or raise HbA1c independent of glycemic control.

Treatment Approach

Even as prediabetes, this patient requires intensive intervention given the borderline-high glucose values:

• Intensive lifestyle modification (calorie restriction, ≥150 minutes/week physical activity, self-monitoring, motivational support) decreases diabetes incidence by 6.2 cases per 100 person-years over 3 years 4
• Metformin decreases diabetes risk by 3.2 cases per 100 person-years and is most effective for those with BMI ≥35, FPG ≥110 mg/dL, or HbA1c ≥6.0% 4
• Lifestyle modification produces larger benefits than metformin and should be first-line therapy 4